Cited 15 times in
Controversies in surveillance and early diagnosis of hepatocellular carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김도영 | - |
dc.contributor.author | 안상훈 | - |
dc.date.accessioned | 2014-12-20T17:46:38Z | - |
dc.date.available | 2014-12-20T17:46:38Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 0030-2414 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/95230 | - |
dc.description.abstract | The surveillance of hepatocellular carcinoma (HCC) is an established approach to detect early cancers in patients with defined risks. However, there are still varied controversies and issues to be addressed regarding the optimal surveillance methods and interval. Moreover, there are discrepancies in the opinion or practice of HCC surveillance between Eastern and Western countries. The Western strategy of ultrasound without a biomarker such as α-fetoprotein reflects the cost-effective utilization of limited resources. On the contrary, combined measurements of biomarkers in Eastern countries are based on the assumption that increased detection of early cancers could result in an overall survival benefit. To address this complicated issue, a prospective study comparing different surveillance tests might be required. More importantly, discovery of a novel biomarker with higher performance would be an alternative. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 56~60 | - |
dc.relation.isPartOf | ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Biomarkers, Tumor/analysis | - |
dc.subject.MESH | Carcinoma, Hepatocellular/diagnosis* | - |
dc.subject.MESH | Carcinoma, Hepatocellular/diagnostic imaging | - |
dc.subject.MESH | Carcinoma, Hepatocellular/virology | - |
dc.subject.MESH | Early Detection of Cancer/methods* | - |
dc.subject.MESH | Hepacivirus/pathogenicity | - |
dc.subject.MESH | Hepatitis B/complications | - |
dc.subject.MESH | Hepatitis B/virology | - |
dc.subject.MESH | Hepatitis C/complications | - |
dc.subject.MESH | Hepatitis C/virology | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Neoplasms/diagnosis* | - |
dc.subject.MESH | Liver Neoplasms/diagnostic imaging | - |
dc.subject.MESH | Liver Neoplasms/virology | - |
dc.subject.MESH | Population Surveillance/methods* | - |
dc.subject.MESH | Ultrasonography, Doppler | - |
dc.subject.MESH | alpha-Fetoproteins/analysis | - |
dc.title | Controversies in surveillance and early diagnosis of hepatocellular carcinoma | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Kim D.Y. | - |
dc.contributor.googleauthor | Kim J.W. | - |
dc.contributor.googleauthor | Kuromatsu R. | - |
dc.contributor.googleauthor | Ahn S.H. | - |
dc.contributor.googleauthor | Torimura T. | - |
dc.contributor.googleauthor | Sherman M. | - |
dc.identifier.doi | 10.1159/000333261 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02226 | - |
dc.contributor.localId | A00385 | - |
dc.relation.journalcode | J02416 | - |
dc.identifier.eissn | 1423-0232 | - |
dc.identifier.pmid | 22212937 | - |
dc.identifier.url | http://www.karger.com/Article/FullText/333261 | - |
dc.subject.keyword | Hepatocellular carcinoma | - |
dc.subject.keyword | Surveillance | - |
dc.subject.keyword | Biomarker | - |
dc.contributor.alternativeName | Kim, Do Young | - |
dc.contributor.alternativeName | Ahn, Sang Hoon | - |
dc.contributor.affiliatedAuthor | Ahn, Sang Hoon | - |
dc.contributor.affiliatedAuthor | Kim, Do Young | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 81 | - |
dc.citation.number | suppl 1 | - |
dc.citation.startPage | 56 | - |
dc.citation.endPage | 60 | - |
dc.identifier.bibliographicCitation | ONCOLOGY, Vol.81(suppl 1) : 56-60, 2011 | - |
dc.identifier.rimsid | 28191 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.